FLPUTNAM INVESTMENT MANAGEMENT CO
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1140334
PORTLAND, ME
Position in LCTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$398,976
New position
Shares Held
304,562
first reported quarter
Ownership
0.120%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 130 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 30%
Shared 0%
None 70%
Position in Biotechnology
Healthcare · as of Jun 30, 2026FLPUTNAM INVESTMENT MANAGEMENT CO holds $54,398,523 across 13 Biotechnology names. LCTX ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
40,116 | $19,926,820 | |
| 2 | TRVI |
Trevi Therapeutics, Inc.
|
1,038,057 | $19,359,763 | |
| 3 | KZIA |
Kazia Therapeutics Ltd
|
414,958 | $5,842,608 | |
| 4 | ZVRA |
Zevra Therapeutics, Inc.
|
348,824 | $5,002,136 | |
| 5 | DYN |
Dyne Therapeutics, Inc.
|
52,975 | $1,176,574 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,761 | $831,143 | |
| 7 | GNLX |
GENELUX Corp
|
231,405 | $696,529 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
939 | $585,504 |
All Filings in LCTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $398,976 | 304,562 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||